In December 2020, a paper was published in the journal BMJ Paediatrics Open, a respected journal with a relatively modest impact factor of 2.496, regarding paediatric medicinal product availability in Scandinavia (Norway, Sweden, Finland and Denmark). Harris Dalrymple and Mark Sorrentino at Center for Pediatric Clinical Development analyse the Scandinavian study’s implications for the development of the paediatric department.